CNMD vs MMSI

For growth investors, Merit Medical Systems, Inc.

(MMSI) is the stronger pick with 11. 7% revenue growth year-over-year, versus 5. 2% for CONMED Corporation (CNMD). CONMED Corporation (CNMD) offers the better valuation at 24. 7x trailing P/E (8. 5x forward), making it the more compelling value choice. Analysts rate Merit Medical Systems, Inc. (MMSI) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CONMED Corporation (CNMD) is the cheapest at 24.

7x versus Merit Medical Systems, Inc. at 28. 9x. On forward P/E, CONMED Corporation is actually cheaper at 8. 5x.

Over the past 5 years, Merit Medical Systems, Inc.

(MMSI) delivered a total return of -5. 0%, compared to -71. 3% for CONMED Corporation (CNMD). Over 10 years, the gap is even starker: MMSI returned +215. 9% versus CNMD's +4. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Merit Medical Systems, Inc.

(MMSI) is the lower-risk stock at 0. 71β versus CONMED Corporation's 1. 34β — meaning CNMD is approximately 88% more volatile than MMSI relative to the S&P 500. On balance sheet safety, Merit Medical Systems, Inc. (MMSI) carries a lower debt/equity ratio of 57% versus 81% for CONMED Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Merit Medical Systems, Inc.

(MMSI) is pulling ahead at 11. 7% versus 5. 2% for CONMED Corporation (CNMD). On earnings-per-share growth, the picture is similar: Merit Medical Systems, Inc. grew EPS 4. 9% year-over-year, compared to -64. 6% for CONMED Corporation. Over a 3-year CAGR, MMSI leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Merit Medical Systems, Inc.

(MMSI) is the more profitable company, earning 8. 5% net margin versus 3. 4% for CONMED Corporation — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MMSI leads at 12. 2% versus 10. 3% for CNMD. At the gross margin level — before operating expenses — CNMD leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, CONMED Corporation (CNMD) trades at 8.

5x forward P/E versus 15. 3x for Merit Medical Systems, Inc. — 6. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNMD: 109. 0% to $78. 00.

In this comparison, CNMD (2.

1% yield) pays a dividend. MMSI does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Merit Medical Systems, Inc.

(MMSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), +215. 9% 10Y return). Both have compounded well over 10 years (MMSI: +215. 9%, CNMD: +4. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

CNMD pays a dividend while MMSI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.